
GlyNAC (Glycine and N-Acetylcysteine)
GlyNAC has a handful of small human studies, nearly all from one research group. In a 16-week randomized trial in 24 adults aged 61 to 80 with overweight, the GlyNAC group's red cell glutathione, oxidative stress markers, insulin resistance, walking speed, grip strength and waist size improved from their starting values, while the placebo group's did not. In an earlier open-label study, the gains faded after people stopped. A 2-week Nestlé trial in 114 healthy older adults found no rise in blood glutathione overall. The Baylor studies used large doses (100 mg per kg of body weight a day of each). No study has measured falls, disability or survival.
Quick decision guide
May help most
Older adults curious about an experimental approach to age-related oxidative stress, who accept that the evidence is small and mostly from one research group and who check with their doctor first
Common dosing range
Studied doses: 100 mg per kg of body weight a day each of glycine and NAC (Baylor trials); 1.2 to 3.6 g of each a day in two doses (Nestlé trial)
When to expect effects
Blood glutathione changes were measured at 2 weeks; walking speed and strength at 16 to 24 weeks
Watch out for
The evidence is small and mostly from one group, and the studied doses are large (several grams of each a day). NAC taken by mouth can cause stomach upset, nausea, vomiting and rash. Not studied in pregnancy. In mouse studies NAC sped up lung cancer growth and melanoma spread, so people with cancer should ask their oncologist first
What is it
GlyNAC is the name researchers at Baylor College of Medicine in Houston gave to taking two supplements together: the amino acid glycine and N-acetylcysteine (NAC), a form of the amino acid cysteine. Together with glutamate, glycine and cysteine are the building blocks of glutathione, one of the main antioxidants inside cells. Most published human studies come from one research group led by Dr. Rajagopal Sekhar, in small groups of older adults, people with type 2 diabetes and people with HIV. One larger 2-week trial was run by Nestlé, which, as the paper declares, holds patents and markets products for glycine plus NAC. NAC is also an FDA-approved drug, first approved in 1963 as Mucomyst. FDA has said that this approval excludes NAC from the dietary supplement definition, but since 2022 it has used enforcement discretion for NAC products labeled as dietary supplements, and on November 17, 2026 it proposed a rule that would allow NAC to be lawfully sold as a dietary supplement (comments close January 19, 2027).
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
glutathione and oxidative stress markers in older adults Limited Evidence | Red cell glutathione 0.4 to 1.4 mmol/L with GlyNAC; no change with placebo (small trial) | Adults over 60 with low glutathione, as studied by the Baylor group | 2 to 16 weeks |
walking speed, grip strength and waist size in older adults Limited Evidence | Walking speed +0.21 m/s and grip +4.4 kg from baseline in 11 people; no change with placebo | Adults aged 61 to 80 with overweight and no diabetes, as studied | 16 to 24 weeks |
blood glutathione in healthy older adults over 2 weeks Limited Evidence | No difference from placebo in total glutathione or the glutathione ratio | Healthy older adults, as studied | 2 weeks |
insulin resistance in older adults, type 2 diabetes and HIV Mixed Evidence | Insulin resistance 22% to 69% lower from baseline in groups of 8 to 12 | Small groups of older adults, adults with type 2 diabetes and adults with HIV, as studied | 2 to 16 weeks |
glutathione and oxidative stress markers in older adults
- Effect
- Red cell glutathione 0.4 to 1.4 mmol/L with GlyNAC; no change with placebo (small trial)
- Best fit
- Adults over 60 with low glutathione, as studied by the Baylor group
- Time
- 2 to 16 weeks
walking speed, grip strength and waist size in older adults
- Effect
- Walking speed +0.21 m/s and grip +4.4 kg from baseline in 11 people; no change with placebo
- Best fit
- Adults aged 61 to 80 with overweight and no diabetes, as studied
- Time
- 16 to 24 weeks
blood glutathione in healthy older adults over 2 weeks
- Effect
- No difference from placebo in total glutathione or the glutathione ratio
- Best fit
- Healthy older adults, as studied
- Time
- 2 weeks
insulin resistance in older adults, type 2 diabetes and HIV
- Effect
- Insulin resistance 22% to 69% lower from baseline in groups of 8 to 12
- Best fit
- Small groups of older adults, adults with type 2 diabetes and adults with HIV, as studied
- Time
- 2 to 16 weeks
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
glutathione and oxidative stress markers in older adults
Biomarker supportIn a double-blind trial at Baylor College of Medicine, 24 adults aged 61 to 80 with a body mass index over 27 and no diabetes were randomized to GlyNAC (100 mg per kg a day each of glycine and NAC) or an alanine placebo for 16 weeks; 11 of 12 in the GlyNAC group completed it. Red blood cell glutathione rose from 0.4 to 1.4 mmol/L of red cells (the level of the young comparison group) and muscle glutathione from 2.4 to 6.3 mmol/kg, while the placebo group stayed at 0.5 and about 2.4; markers of oxidative damage fell to levels similar to young adults. Earlier, in 8 older adults, 2 weeks of glycine plus cysteine raised red cell glutathione by 94.6%, and an open-label pilot in 8 adults aged 71 to 80 found similar changes after 24 weeks. The randomized trial was funded by the National Institute on Aging and the McNair Medical Institute, and its authors declared no conflicts. Each group was compared with its own starting values, and the trial was powered only for the glutathione result.
Bottom line: Small studies from one group found large rises in glutathione; a larger industry trial did not, so the finding is not settled.
Evidence is mixed
In a Nestlé-run randomized trial of 114 healthy adults aged 60 to 85 (mean age 65), 2 weeks of 1.2 to 3.6 g a day each of glycine and NAC did not raise total blood glutathione (903.5 with placebo vs 959.6 mg/L with the highest dose, p = 0.278) or the reduced-to-oxidized glutathione ratio, the main outcomes. Only a subgroup with high oxidative stress and low starting glutathione, found in an analysis after the fact, had higher glutathione (819.7 vs 905.4 mg/L, p = 0.016).
walking speed, grip strength and waist size in older adults
Supplement benefitIn the same 16-week randomized trial (24 adults aged 61 to 80 with overweight), the GlyNAC group's walking speed rose from 1.13 to 1.34 meters per second (p = .032), dominant-hand grip strength from 32.3 to 36.7 kg (p = .004), and the chair-rise test time fell from 25.6 to 18.8 seconds (p = .002); the 6-minute walk rose from 522.5 to 564.8 m, which was not statistically significant (p = .053). Waist size fell from 1.06 to 1.03 m and systolic blood pressure from 132.0 to 124.4 mmHg. None of these changed in the placebo group (walking speed 1.11 to 1.16 m/s). These are within-group changes from baseline in 11 to 12 people per group. In an earlier open-label pilot of 8 adults aged 71 to 80, walking speed rose from 1.0 to 1.5 m/s after 24 weeks and Montreal Cognitive Assessment scores from 26.0 to 28.8, but both fell back (to 1.2 m/s and 27.5) 12 weeks after stopping. Falls, disability and independence were not measured.
Bottom line: One small trial and one 8-person pilot found better walking speed and grip; this needs confirmation in larger trials with real-life outcomes.
blood glutathione in healthy older adults over 2 weeks
No benefit foundIn a randomized, placebo-controlled trial run by Nestlé researchers in Germany, 114 healthy adults aged 60 to 85 (mean age 65) took 1.2, 2.4 or 3.6 g a day each of glycine and NAC, or an isomaltulose placebo, for 2 weeks. The main outcomes, total blood glutathione and the ratio of reduced to oxidized glutathione, did not differ from placebo (total glutathione 903.5 vs 959.6 mg/L at the highest dose, p = 0.278; ratio 12.49 vs 12.65, p = 0.739). In an analysis done afterward, people with high oxidative stress and low starting glutathione on the two higher doses had higher glutathione (819.7 vs 905.4 mg/L, p = 0.016). No severe adverse effects were reported. Nestlé Health Science holds patents and markets products for glycine plus NAC, and the study authors were Nestlé employees or worked for a research company it funded.
Bottom line: The largest trial found no overall rise in blood glutathione after 2 weeks in healthy older adults.
insulin resistance in older adults, type 2 diabetes and HIV
Biomarker supportIn the 16-week randomized trial, insulin resistance (HOMA-IR) fell by 64% and fasting insulin by 65% in the GlyNAC group, but fasting glucose and glucose tolerance tests did not change. In 10 adults with type 2 diabetes (mean age about 51), 14 days of 100 mg per kg a day each of glycine and NAC, without a placebo group, lowered insulin resistance by 22%, raised fasting fat burning by mitochondria by 30% and lowered blood free fatty acids by 25%; HbA1c did not change over the 2 weeks (9.2 to 9.1%). This study was funded by Baylor seed funding. In 8 people with HIV aged 45 to 65 on stable treatment, 12 weeks of open-label GlyNAC lowered insulin resistance by 69%, with no adverse effects; it was funded by an HIV and aging pilot grant and the McNair Medical Institute. These are blood markers in very small groups, and blood sugar control was not shown to improve.
Bottom line: Insulin-resistance markers improved in very small studies, mostly without placebo; blood sugar did not change.
How it works
How to take it
What to track
Bottom line: Small studies from one group show blood-marker and short-test improvements at large doses; the one larger trial was short and found no overall glutathione rise.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Large doses, little long-term data. The Baylor studies gave 100 mg per kg a day of each (about 7 g of each a day for a 70 kg adult) for up to 24 weeks, in groups of 8 to 12. FDA's 2026 review of 41 studies of NAC taken by mouth found a minimal level of concern: one study found more nausea with NAC, and the others reported no adverse events or no significant difference from comparison groups, at doses from 200 to 9,000 mg a day for 5 days to 3 years, but it reviewed NAC alone, not the combination with glycine.
Cancer growth in animal studies. In mouse models of lung cancer, NAC added to the diet markedly increased tumor progression and shortened survival, and in a mouse model of melanoma NAC increased spread to the lymph nodes, an effect that depended on new glutathione synthesis. These are animal findings and have not been studied in people taking GlyNAC.
Who should avoid it
- People with cancer or a history of cancer, unless their oncologist agrees: NAC sped up tumor growth and spread in mice
- People with abnormal liver or kidney blood tests, diabetes, untreated heart disease or active cancer, unless their doctor agrees: the randomized trial excluded them (liver enzymes over twice the upper limit of normal, creatinine over 1.5 mg/dL), and asked participants to avoid acetaminophen and alcoholSourceKumar et al., 2023 · PMC
Pregnancy & breastfeeding
Pregnancy: we found no study of GlyNAC in pregnancy, and the randomized trial excluded pregnant women. Breastfeeding: we found no study in breastfeeding women. Ask your obstetric clinician or pharmacist before using it while pregnant, trying to conceive or breastfeeding.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
What is GlyNAC, and is it different from taking NAC alone?⌄
GlyNAC is glycine plus N-acetylcysteine (NAC) taken together, a combination named by researchers at Baylor College of Medicine. Both supply building blocks of glutathione. The Baylor group argues that older adults are short of both glycine and cysteine, so NAC alone is not enough, but no published trial has compared GlyNAC directly with NAC alone or glycine alone.
Does GlyNAC slow aging?⌄
That has not been shown. A 16-week trial in 24 older adults found improvements in blood markers, walking speed, grip strength and waist size compared with each group's starting point, and an 8-person pilot found the gains faded after stopping. A larger 2-week trial found no overall rise in blood glutathione. No study has measured disability, falls or how long people live.
How much did the studies use?⌄
The Baylor studies used 100 mg per kg of body weight a day each of glycine and NAC, which is about 7 g of each a day for a 70 kg adult. The Nestlé trial used 1.2 to 3.6 g of each a day split into two doses. These are studied doses, not recommendations: ask your doctor or pharmacist whether any amount suits you.
Who ran and paid for the studies?⌄
Most were run by Dr. Rajagopal Sekhar's group at Baylor College of Medicine and were funded by the National Institute on Aging, the McNair Medical Institute and other grants; the authors declared no conflicts of interest. The 114-person trial was run by Nestlé researchers, and Nestlé Health Science holds patents and markets products for glycine plus NAC.
Is NAC allowed in dietary supplements?⌄
FDA says NAC was approved as a drug in 1963, which excludes it from the dietary supplement definition, but since 2022 FDA has said it intends to use enforcement discretion for NAC products labeled as dietary supplements. On November 17, 2026 FDA proposed a rule that would allow NAC to be lawfully marketed as a dietary supplement; comments are open until January 19, 2027.
Can I take GlyNAC with my medicines or supplements?⌄
No interaction studies of the combination exist. Glycine and NAC each have their own pages that list their checked interactions, so look up both. Ask your doctor or pharmacist to review your full list, especially if you are being treated for cancer or have surgery planned.
References by claim
glutathione and oxidative stress markers in older adults
insulin resistance in older adults, type 2 diabetes and HIV
Track GlyNAC (Glycine and N-Acetylcysteine) with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments. Talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.
